Cannon Global Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History

Cannon Global Investment Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$40.4K	–	80
2025 Q1	$40.4K	Buy	+10,000	New	+$33.3K	0.07%	78

Cannon Global Investment Management's CKPT Position: Q2 2025 in Review

Cannon Global Investment Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,000 shares — an estimated $40.4K sold.

Cannon Global Investment Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $40.4K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Cannon Global Investment Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Cannon Global Investment Management sold 10,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $40.4K.
Cannon Global Investment Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Cannon Global Investment Management's Checkpoint Therapeutics position peaked at $40.4K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Cannon Global Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.